In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping

N/ANot Yet RecruitingNCT07011212

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud332 enrolled

Overview

Testing a clinical decision tool (BL-Predictor)

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

332

Conditions

Drug Allergy

Interventions

BL-PredicterDIAGNOSTIC_TEST

To Clinically validate the BL-Predictor toll by a randomised conytrolled ttrial

Eligibility

Sex: ALLMin age: 14 Years

Medical Language ↔ Plain English

Inclusion Criteria: * signed informed consnet Exclusion Criteria: * Use of immunomodulators, antihistamines and corticosteroids

Outcomes

Primary Outcomes

The main goal of this project is to test a cliniacl decision toll to stratify BL allergic pataients in low and mediaum- anf high-risk

And to carry out a deep dissection of the cellular mechanisms of B cells sensitization and basophil and neutrophil activation in BL-IRs to develop accurate in vitro diagnostic test

Time frame: April 2029- june 2027

Central Contacts

Marina Labella Alvarez MLB Bonilla Toyos

CONTACT

+34951032058 elvira.bonilla@ibima.eu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.